Beam Therapeutics Insider Trades
NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 25.84 +0.54%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 30 · $18.56M
- Shares bought / sold
- 0 / 582.11K
- Net activity
- Net selling $18.6 million
Beam Therapeutics insider activity
Over the last 12 months, Beam Therapeutics insiders reported 49 transactions on SEC Form 4: 0 open-market purchases and 30 sales. Insiders bought $0 and sold $18.6 million worth of stock, for net insider selling of $18.6 million. The largest seller was FMR LLC, with $10.1 million in reported sales.
The most recent filing shows Cavanagh Bethany J (SVP, Finance and Treasurer) selling 187 shares at $24.41 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BEAM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BEAM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer | Sale | 187 | $4.56K | Form 4 |
| Sep 24, 2026 | Ciaramella GiuseppePresident | Gift | 123,407 | — | Form 4 |
| Jul 27, 2026 | Simon AmyChief Medical Officer | Sale | 16,667 | $429.04K | Form 4 |
| Jun 30, 2026 | Evans John M.CEO | Sale | 1,900 | $66.20K | Form 4 |
| Jun 30, 2026 | Evans John M.CEO | Sale | 23,100 | $791.48K | Form 4 |
| Jun 30, 2026 | Evans John M.CEO | Option exercise | 25,000 | $25.75K | Form 4 |
| Jun 30, 2026 | Simon AmyChief Medical Officer | Sale | 373 | $12.95K | Form 4 |
| Jun 29, 2026 | Evans John M.CEO | Sale | 11,579 | $415.82K | Form 4 |
| Jun 29, 2026 | Evans John M.CEO | Sale | 13,421 | $471.53K | Form 4 |
| Jun 29, 2026 | Evans John M.CEO | Option exercise | 6,337 | $6.53K | Form 4 |
| Jun 29, 2026 | Evans John M.CEO | Option exercise | 18,663 | $12.50K | Form 4 |
| Jun 26, 2026 | FMR LLC10% Owner | Sale | 251,488 | $8.87M | Form 4 |
| Jun 25, 2026 | FMR LLC10% Owner | Sale | 33,372 | $1.17M | Form 4 |
| Jun 17, 2026 | Ciaramella GiuseppePresident | Option exercise | 29,000 | $29.87K | Form 4 |
| Jun 17, 2026 | Ciaramella GiuseppePresident | Option exercise | 6,505 | $4.36K | Form 4 |
| Apr 1, 2026 | Ciaramella GiuseppePresident | Sale | 11,810 | $290.29K | Form 4 |
| Apr 1, 2026 | Bellon ChristineChief Legal Officer | Sale | 5,956 | $146.40K | Form 4 |
| Apr 1, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer | Sale | 3,242 | $79.69K | Form 4 |
| Apr 1, 2026 | Simon AmyChief Medical Officer | Sale | 6,700 | $164.69K | Form 4 |
| Apr 1, 2026 | Evans John M.CEO | Sale | 30,078 | $739.32K | Form 4 |
| Mar 31, 2026 | Evans John M.CEO | Award | 90,000 | — | Form 4 |
| Mar 31, 2026 | Evans John M.CEO | Sale | 25,000 | $569.09K | Form 4 |
| Mar 31, 2026 | Evans John M.CEO | Option exercise | 25,000 | $16.75K | Form 4 |
| Mar 31, 2026 | Ciaramella GiuseppePresident | Award | 40,000 | — | Form 4 |
| Mar 31, 2026 | Bellon ChristineChief Legal Officer | Award | 20,000 | — | Form 4 |
| Mar 31, 2026 | Emany Sravan KumarChief Financial Officer | Award | 31,750 | — | Form 4 |
| Mar 31, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer | Award | 20,000 | — | Form 4 |
| Mar 31, 2026 | Simon AmyChief Medical Officer | Award | 31,750 | — | Form 4 |
| Mar 30, 2026 | Evans John M.CEO | Sale | 25,000 | $559.23K | Form 4 |
| Mar 30, 2026 | Evans John M.CEO | Option exercise | 25,000 | $16.75K | Form 4 |
| Feb 24, 2026 | Ciaramella GiuseppePresident | Sale | 35,000 | $1.12M | Form 4 |
| Feb 24, 2026 | Ciaramella GiuseppePresident | Option exercise | 35,000 | $595.00K | Form 4 |
| Jan 30, 2026 | Evans John M.CEO | Sale | 2,906 | $84.27K | Form 4 |
| Jan 30, 2026 | Evans John M.CEO | Sale | 22,094 | $624.67K | Form 4 |
| Jan 30, 2026 | Evans John M.CEO | Option exercise | 25,000 | $16.75K | Form 4 |
| Jan 29, 2026 | Evans John M.CEO | Sale | 8,667 | $257.78K | Form 4 |
| Jan 29, 2026 | Evans John M.CEO | Sale | 16,333 | $476.80K | Form 4 |
| Jan 29, 2026 | Evans John M.CEO | Option exercise | 5,664 | $3.79K | Form 4 |
| Jan 29, 2026 | Evans John M.CEO | Option exercise | 19,336 | $12.96K | Form 4 |
| Jan 22, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer | Sale | 6,198 | $216.93K | Form 4 |
| Jan 22, 2026 | Bellon ChristineChief Legal Officer | Sale | 1,371 | $46.61K | Form 4 |
| Jan 20, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer | Sale | 3,034 | $91.38K | Form 4 |
| Jan 15, 2026 | Bellon ChristineChief Legal Officer | Sale | 559 | $19.79K | Form 4 |
| Jan 15, 2026 | Bellon ChristineChief Legal Officer | Sale | 15,959 | $554.07K | Form 4 |
| Jan 15, 2026 | Bellon ChristineChief Legal Officer | Sale | 2,111 | $70.98K | Form 4 |
| Dec 31, 2025 | Simon AmyChief Medical Officer | Award | 12,500 | — | Form 4 |
| Dec 31, 2025 | Emany Sravan KumarChief Financial Officer | Sale | 6,294 | $170.57K | Form 4 |
| Dec 31, 2025 | Bellon ChristineChief Legal Officer | Sale | 1,254 | $33.98K | Form 4 |
| Oct 27, 2025 | FMR LLC10% Owner | Sale | 459 | $12.25K | Form 4 |
| Oct 6, 2025 | FMR LLC10% Owner | Gift | 1,232,434 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4